$NASDAQ:ILMN - analysis of annual cot levelsNASDAQ:ILMN
Please remember that this idea does not constitute investment advice.
After a personal analysis of the institutional value of the COT, buy and sell program levels are outlined. Since the asset is at its minimum, the idea is to wait for the price to head inside the buy program, wait fo
Key facts today
BofA Securities has lowered its price target for Illumina (ILMN) from $90 to $75, while keeping an 'underperform' rating on the stock.
Bank of America analysts warn that Illumina may face challenges in 2025 due to NIH budget cuts and economic headwinds, with risks likely surfacing in the second and third quarters.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.69 USD
−1.22 B USD
4.37 B USD
153.56 M
About Illumina, Inc.
Sector
Industry
CEO
Jacob Thaysen
Website
Headquarters
San Diego
Founded
1998
FIGI
BBG000DSMS70
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
ILMN Illumina Options Ahead of Earnings Analyzing the options chain and the chart patterns of ILMN Illumina prior to the earnings report this week,
I would consider purchasing the 140usd strike price in the money Calls with
an expiration date of 2024-12-20,
for a premium of approximately $16.65.
If these options prove to be profitable pri
ILMN Long PositionHi traders,
Taking a closer look at Illumina, Inc. (ILMN), we can observe the formation of a falling wedge pattern over the past few weeks, indicating a potential bullish reversal.
Illumina, a leading developer of life science tools and integrated systems for large-scale analysis of genetic variati
ILMN Bullish ComebackOn the 12 month timeframe, or yearly supercycle, ILMN seems to be consolidating enough these first 3 months into 2024 to ultimately flip to the upside with maximum bull force. The company has a solid catalyst with AI facilitating the end goal of a super biopharma product that perhaps all humanity ma
Ending diagonal heralds the beginning of a prolonged bear marketAn ending diagonal starting from March 2020 is seen on the chart for ILLUMINA. This pattern usually signals exhaustion at the end of a bull cycle and the start of a bear market. As seen on the log scale (monthly or weekly), ILLUMINA has been slowly losing momentum for the past decade. Although it
ILMN Illumina Options Ahead of EarningsAnalyzing the options chain and the chart patterns of ILMN Illumina prior to the earnings report this week,
I would consider purchasing the 195usd strike price Calls with
an expiration date of 2023-9-15,
for a premium of approximately $8.15.
If these options prove to be profitable prior to the earni
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ILMN5150650
Illumina, Inc. 2.55% 23-MAR-2031Yield to maturity
6.09%
Maturity date
Mar 23, 2031
ILMN5508412
Illumina, Inc. 5.75% 13-DEC-2027Yield to maturity
5.31%
Maturity date
Dec 13, 2027
ILMN5508411
Illumina, Inc. 5.8% 12-DEC-2025Yield to maturity
4.81%
Maturity date
Dec 12, 2025
ILMN5886317
Illumina, Inc. 4.65% 09-SEP-2026Yield to maturity
4.71%
Maturity date
Sep 9, 2026
See all ILMN bonds
Curated watchlists where ILMN is featured.
Related stocks
Frequently Asked Questions
The current price of ILMN is 75.06 USD — it has increased by 0.37% in the past 24 hours. Watch Illumina, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Illumina, Inc. stocks are traded under the ticker ILMN.
ILMN stock has risen by 6.30% compared to the previous week, the month change is a −11.38% fall, over the last year Illumina, Inc. has showed a −40.13% decrease.
We've gathered analysts' opinions on Illumina, Inc. future price: according to them, ILMN price has a max estimate of 190.00 USD and a min estimate of 75.00 USD. Watch ILMN chart and read a more detailed Illumina, Inc. stock forecast: see what analysts think of Illumina, Inc. and suggest that you do with its stocks.
ILMN reached its all-time high on Feb 12, 2021 with the price of 540.12 USD, and its all-time low was 0.83 USD and was reached on Mar 13, 2003. View more price dynamics on ILMN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ILMN stock is 2.73% volatile and has beta coefficient of 0.89. Track Illumina, Inc. stock price on the chart and check out the list of the most volatile stocks — is Illumina, Inc. there?
Today Illumina, Inc. has the market capitalization of 11.88 B, it has decreased by −6.30% over the last week.
Yes, you can track Illumina, Inc. financials in yearly and quarterly reports right on TradingView.
Illumina, Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
ILMN earnings for the last quarter are 0.95 USD per share, whereas the estimation was 0.91 USD resulting in a 4.07% surprise. The estimated earnings for the next quarter are 0.94 USD per share. See more details about Illumina, Inc. earnings.
Illumina, Inc. revenue for the last quarter amounts to 1.10 B USD, despite the estimated figure of 1.09 B USD. In the next quarter, revenue is expected to reach 1.03 B USD.
ILMN net income for the last quarter is 187.00 M USD, while the quarter before that showed 705.00 M USD of net income which accounts for −73.48% change. Track more Illumina, Inc. financial stats to get the full picture.
No, ILMN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 10.37 K employees. See our rating of the largest employees — is Illumina, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Illumina, Inc. EBITDA is 1.53 B USD, and current EBITDA margin is 17.25%. See more stats in Illumina, Inc. financial statements.
Like other stocks, ILMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Illumina, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Illumina, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Illumina, Inc. stock shows the sell signal. See more of Illumina, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.